Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
MAP Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Sell | $9.6K | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Sell | $291.2K | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Sell | $43.3K | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Sell | $64.4K | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
MAP Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC |